BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15234573)

  • 1. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
    Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
    Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
    Tussié-Luna MI; Rozo L; Roy AL
    Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis.
    Kamel-Reid S; Zhang T; Wells RA
    Oncogene; 2003 Sep; 22(41):6424-35. PubMed ID: 14508522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
    Imaizumi M; Suzuki H; Yoshinari M; Sato A; Saito T; Sugawara A; Tsuchiya S; Hatae Y; Fujimoto T; Kakizuka A; Konno T; Iinuma K
    Blood; 1998 Jul; 92(2):374-82. PubMed ID: 9657734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
    Mozziconacci MJ; Rosenauer A; Restouin A; Fanelli M; Shao W; Fernandez F; Toiron Y; Viscardi J; Gambacorti-Passerini C; Miller WH; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 2002 Nov; 35(3):261-70. PubMed ID: 12353268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
    Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
    Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
    Bhatia M; Kirkland JB; Meckling-Gill KA
    Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
    Chen Z; Wang W; Pan J; Chen L; Xue Y
    Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
    Coltella N; Valsecchi R; Ponente M; Ponzoni M; Bernardi R
    Clin Cancer Res; 2015 Aug; 21(16):3685-94. PubMed ID: 25931453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
    Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
    Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
    Li L; Wang J; Ye RD; Shi G; Jin H; Tang X; Yi J
    J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of
    Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
    J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.
    Côté S; Rosenauer A; Bianchini A; Seiter K; Vandewiele J; Nervi C; Miller WH
    Blood; 2002 Oct; 100(7):2586-96. PubMed ID: 12239173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutation in the PML/RARalpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia.
    Takayama N; Kizaki M; Hida T; Kinjo K; Ikeda Y
    Exp Hematol; 2001 Jul; 29(7):864-72. PubMed ID: 11438209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells.
    Arlt A; Minkenberg J; Kocs B; Grossmann M; Kruse ML; Fölsch UR; Schäfer H
    Leukemia; 2004 Oct; 18(10):1646-55. PubMed ID: 15306824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.